男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

組織蛋白酶L(CTSL)多克隆抗體(生物素標(biāo)記)

Biotin-Linked Polyclonal Antibody to Cathepsin L (CTSL)

CTSL1; CATL; CTS-L; MEP; Cathepsin L1; Major excreted protein

  • 組織蛋白酶L(CTSL)多克隆抗體(生物素標(biāo)記)產(chǎn)品包裝(模擬)
  • 組織蛋白酶L(CTSL)多克隆抗體(生物素標(biāo)記)產(chǎn)品包裝(模擬)
  • 組織蛋白酶L(CTSL)多克隆抗體(生物素標(biāo)記)Western Blot; Sample: Mouse Lung lysate
    Primary Ab: 0.2μg/ml Biotin-Linked Polyclonal Antibody to Cathepsin L (CTSL)
    Second Ab: 0.2μg/ml HRP-Labeled Streptavidin (Catalog: IS089)
  • Certificate通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對CTSL的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別CTSL。

用法

免疫印跡:0.2-2μg/mL;1:250-2500
免疫組織化學(xué):5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué):5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。

贈品

相關(guān)產(chǎn)品

編號適用物種:Homo sapiens (Human,人)應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPA306Hu01組織蛋白酶L(CTSL)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA306Hu01組織蛋白酶L(CTSL)多克隆抗體WB; ICC/IF
LAA306Hu71組織蛋白酶L(CTSL)多克隆抗體(生物素標(biāo)記)WB
MAA306Hu22組織蛋白酶L(CTSL)單克隆抗體WB; IHC; ICC; IP.
SEA306Hu組織蛋白酶L(CTSL)檢測試劑盒(酶聯(lián)免疫吸附試驗法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMA306Hu組織蛋白酶L(CTSL)等多因子檢測試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志參考文獻(xiàn)
HypertensionIdentification of Cathepsin L as a Potential Sex-Specific Biomarker for Renal Damage. [Ahajournals: source]
The Journal of International Medical ResearchPlasma Cathepsin L and Its Related Pro/Antiangiogenic Factors Play Useful Roles in Predicting Rich Coronary Collaterals in Patients with Coronary Heart Disease[Ingenta: art00021]
Atherosclerosis.?Biochemical and clinical correlation of intraplaque neovascularization using contrast-enhanced ultrasound of the carotid artery[Pubmed:24534452]
International Journal of Molecular SciencesA New Analytical Method for Determination of Cathepsin L Based on the Surface Plasmon Resonance Imaging Biosensor[Pubmed: 31052424]
EMBO Molecular MedicineImmune‐mediated ECM depletion improves tumour perfusion and payload delivery[Pubmed: 31709774]
Cardiovasc ResInhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size[34132807]